All Categories
Contact Us

BEVICRA 100MG INJ

Brand: BEVICRA 100MG INJ
Composition: bevacizumab 100mg
Company: Glenmark
Form : injection
Packing: injection
Request a Quote
Share :

Related Products

Topotec 2.5mg

BEVICRA 100MG INJ is a prescription medication used to treat various types of cancer, including:
  • Metastatic colorectal cancer (mCRC)
  • Non-small cell lung cancer (NSCLC)
  • Renal cell carcinoma (RCC)
  • Breast cancer
  • Brain cancer
  • Ovarian cancer
It is a monoclonal antibody that works by blocking the action of vascular endothelial growth factor (VEGF), a protein that helps form new blood vessels that feed tumors. Composition: Each vial of BEVICRA 100MG INJ contains 100mg of bevacizumab. Mechanism of Action: Bevacizumab works by:
  • Binding to VEGF and preventing it from binding to its receptors on the surface of endothelial cells
  • Inhibiting the growth of new blood vessels that feed the tumor
  • Reducing the amount of oxygen and nutrients that reach the tumor, leading to its shrinkage and eventual death
Uses: BEVICRA 100MG INJ is used to treat various types of cancer, including:
  • Metastatic colorectal cancer (mCRC) in combination with chemotherapy
  • Non-small cell lung cancer (NSCLC) in combination with chemotherapy
  • Renal cell carcinoma (RCC) in combination with interferon alfa
  • Breast cancer in combination with chemotherapy or hormone therapy
  • Brain cancer in combination with chemotherapy
  • Ovarian cancer in combination with chemotherapy
Dosage: The recommended dosage of BEVICRA 100MG INJ is:
  • 100mg administered as an intravenous infusion over 30-60 minutes every 2-3 weeks
Side Effects: Common side effects of BEVICRA 100MG INJ include:
  • Hypertension (high blood pressure)
  • Proteinuria (excess protein in the urine)
  • Hemorrhage (bleeding)
  • Nausea and vomiting
  • Fatigue
  • Headache
  • Rash
  • Diarrhea
Recommendation: BEVICRA 100MG INJ is recommended for patients who have not received prior therapy for their specific type of cancer. Patients should also be advised to monitor their blood pressure and urine output regularly during treatment. Important Note: Patients should not take BEVICRA 100MG INJ if they have a history of severe allergic reactions, bleeding disorders, or eye problems. Patients should also inform their healthcare provider if they have any underlying medical conditions, such as high blood pressure, kidney problems, or seizure disorders, before taking BEVICRA 100MG INJ. Some common brands of bevacizumab include:
  • Avastin (Roche)
  • Mvasi (Amgen)
  • Bevacizumab-awwb (Amgen)
  • Bevacizumab-bvzr (Biocon/Biocon Biologics)

BEVICRA 100MG INJ is a prescription medication used to treat various types of cancer, including:

  • Metastatic colorectal cancer (mCRC)
  • Non-small cell lung cancer (NSCLC)
  • Renal cell carcinoma (RCC)
  • Breast cancer
  • Brain cancer
  • Ovarian cancer

It is a monoclonal antibody that works by blocking the action of vascular endothelial growth factor (VEGF), a protein that helps form new blood vessels that feed tumors.

Composition:

Each vial of BEVICRA 100MG INJ contains 100mg of bevacizumab.

Mechanism of Action:

Bevacizumab works by:

  • Binding to VEGF and preventing it from binding to its receptors on the surface of endothelial cells
  • Inhibiting the growth of new blood vessels that feed the tumor
  • Reducing the amount of oxygen and nutrients that reach the tumor, leading to its shrinkage and eventual death

Uses:

BEVICRA 100MG INJ is used to treat various types of cancer, including:

  • Metastatic colorectal cancer (mCRC) in combination with chemotherapy
  • Non-small cell lung cancer (NSCLC) in combination with chemotherapy
  • Renal cell carcinoma (RCC) in combination with interferon alfa
  • Breast cancer in combination with chemotherapy or hormone therapy
  • Brain cancer in combination with chemotherapy
  • Ovarian cancer in combination with chemotherapy

Dosage:

The recommended dosage of BEVICRA 100MG INJ is:

  • 100mg administered as an intravenous infusion over 30-60 minutes every 2-3 weeks

Side Effects:

Common side effects of BEVICRA 100MG INJ include:

  • Hypertension (high blood pressure)
  • Proteinuria (excess protein in the urine)
  • Hemorrhage (bleeding)
  • Nausea and vomiting
  • Fatigue
  • Headache
  • Rash
  • Diarrhea

Recommendation:

BEVICRA 100MG INJ is recommended for patients who have not received prior therapy for their specific type of cancer. Patients should also be advised to monitor their blood pressure and urine output regularly during treatment.

Important Note:

Patients should not take BEVICRA 100MG INJ if they have a history of severe allergic reactions, bleeding disorders, or eye problems. Patients should also inform their healthcare provider if they have any underlying medical conditions, such as high blood pressure, kidney problems, or seizure disorders, before taking BEVICRA 100MG INJ.

Some common brands of bevacizumab include:

  • Avastin (Roche)
  • Mvasi (Amgen)
  • Bevacizumab-awwb (Amgen)
  • Bevacizumab-bvzr (Biocon/Biocon Biologics)

Shipping Options – 

We offer a variety of shipping options, including Express Mail Service (EMS), USPS, DHL, FedEx, TNT, UPS, Aramex, Air Cargo, and sea freight.

Terms and Conditions – 

Bulk Orders: You are responsible for any local import duties and taxes in your country.

For Patients: When ordering prescription medicines for personal use, or for a friend or relative, a valid medical practitioner’s script or prescription is required.

Return and Refund Policy: Due to the nature of our products, we cannot accept returns or exchanges once a purchase is made. However, in the event of non-delivery, you are eligible for either a 100% refund or a reshipment of your order.

BEVICRA 100MG INJ is a prescription medication used to treat various types of cancer, including:

  • Metastatic colorectal cancer (mCRC)
  • Non-small cell lung cancer (NSCLC)
  • Renal cell carcinoma (RCC)
  • Breast cancer
  • Brain cancer
  • Ovarian cancer

It is a monoclonal antibody that works by blocking the action of vascular endothelial growth factor (VEGF), a protein that helps form new blood vessels that feed tumors.

Composition:

Each vial of BEVICRA 100MG INJ contains 100mg of bevacizumab.

Mechanism of Action:

Bevacizumab works by:

  • Binding to VEGF and preventing it from binding to its receptors on the surface of endothelial cells
  • Inhibiting the growth of new blood vessels that feed the tumor
  • Reducing the amount of oxygen and nutrients that reach the tumor, leading to its shrinkage and eventual death

Uses:

BEVICRA 100MG INJ is used to treat various types of cancer, including:

  • Metastatic colorectal cancer (mCRC) in combination with chemotherapy
  • Non-small cell lung cancer (NSCLC) in combination with chemotherapy
  • Renal cell carcinoma (RCC) in combination with interferon alfa
  • Breast cancer in combination with chemotherapy or hormone therapy
  • Brain cancer in combination with chemotherapy
  • Ovarian cancer in combination with chemotherapy

Dosage:

The recommended dosage of BEVICRA 100MG INJ is:

  • 100mg administered as an intravenous infusion over 30-60 minutes every 2-3 weeks

Side Effects:

Common side effects of BEVICRA 100MG INJ include:

  • Hypertension (high blood pressure)
  • Proteinuria (excess protein in the urine)
  • Hemorrhage (bleeding)
  • Nausea and vomiting
  • Fatigue
  • Headache
  • Rash
  • Diarrhea

Recommendation:

BEVICRA 100MG INJ is recommended for patients who have not received prior therapy for their specific type of cancer. Patients should also be advised to monitor their blood pressure and urine output regularly during treatment.

Important Note:

Patients should not take BEVICRA 100MG INJ if they have a history of severe allergic reactions, bleeding disorders, or eye problems. Patients should also inform their healthcare provider if they have any underlying medical conditions, such as high blood pressure, kidney problems, or seizure disorders, before taking BEVICRA 100MG INJ.

Some common brands of bevacizumab include:

  • Avastin (Roche)
  • Mvasi (Amgen)
  • Bevacizumab-awwb (Amgen)
  • Bevacizumab-bvzr (Biocon/Biocon Biologics)

Reviews

There are no reviews yet.

Be the first to review “BEVICRA 100MG INJ”

Your email address will not be published. Required fields are marked *

BEVICRA 100MG INJ is a prescription medication used to treat various types of cancer, including:

  • Metastatic colorectal cancer (mCRC)
  • Non-small cell lung cancer (NSCLC)
  • Renal cell carcinoma (RCC)
  • Breast cancer
  • Brain cancer
  • Ovarian cancer

It is a monoclonal antibody that works by blocking the action of vascular endothelial growth factor (VEGF), a protein that helps form new blood vessels that feed tumors.

Composition:

Each vial of BEVICRA 100MG INJ contains 100mg of bevacizumab.

Mechanism of Action:

Bevacizumab works by:

  • Binding to VEGF and preventing it from binding to its receptors on the surface of endothelial cells
  • Inhibiting the growth of new blood vessels that feed the tumor
  • Reducing the amount of oxygen and nutrients that reach the tumor, leading to its shrinkage and eventual death

Uses:

BEVICRA 100MG INJ is used to treat various types of cancer, including:

  • Metastatic colorectal cancer (mCRC) in combination with chemotherapy
  • Non-small cell lung cancer (NSCLC) in combination with chemotherapy
  • Renal cell carcinoma (RCC) in combination with interferon alfa
  • Breast cancer in combination with chemotherapy or hormone therapy
  • Brain cancer in combination with chemotherapy
  • Ovarian cancer in combination with chemotherapy

Dosage:

The recommended dosage of BEVICRA 100MG INJ is:

  • 100mg administered as an intravenous infusion over 30-60 minutes every 2-3 weeks

Side Effects:

Common side effects of BEVICRA 100MG INJ include:

  • Hypertension (high blood pressure)
  • Proteinuria (excess protein in the urine)
  • Hemorrhage (bleeding)
  • Nausea and vomiting
  • Fatigue
  • Headache
  • Rash
  • Diarrhea

Recommendation:

BEVICRA 100MG INJ is recommended for patients who have not received prior therapy for their specific type of cancer. Patients should also be advised to monitor their blood pressure and urine output regularly during treatment.

Important Note:

Patients should not take BEVICRA 100MG INJ if they have a history of severe allergic reactions, bleeding disorders, or eye problems. Patients should also inform their healthcare provider if they have any underlying medical conditions, such as high blood pressure, kidney problems, or seizure disorders, before taking BEVICRA 100MG INJ.

Some common brands of bevacizumab include:

  • Avastin (Roche)
  • Mvasi (Amgen)
  • Bevacizumab-awwb (Amgen)
  • Bevacizumab-bvzr (Biocon/Biocon Biologics)

Reviews

There are no reviews yet.

Be the first to review “BEVICRA 100MG INJ”

Your email address will not be published. Required fields are marked *

Medical Disclaimer

Anteka Pharmacy primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on Anteka Pharmacy. Our mission is to support, not replace, the doctor-patient relationship.
abbott
Ferring Pharmaceuticals 1
bdr
celon pharma
alkem
AstraZeneca
Aurobindo
biocon
bsv pharma
cipla
esisi
dr reddy
emsure
lilly
Glenmark Pharmaceuticals
gsk
Fresenius Kabi
gls
hetero
intas pharma
Jenome Biophar
Laurus Labs Limited
Miracalus Pharma
msd
mylan
neaon
Natco Pharma Limited
novartis
Panacea Biotec
Pfizer Inc
Ranbaxy Pharmaceuticals Inc
roche
rgp
Samarth Life
sandoz
sarabhai
sun pharma
torrent pharma
3e963ab60b4cd83959187883e457451f_200x200
zydus
Scroll to Top

Log in

Create an Account

Send Enquiry For BEVICRA 100MG INJ